Travere Therapeutics (TVTX) Reports 144% Annual Growth in Filspari Sales for 2025

2 weeks ago 10

Maham Fatima

Tue, February 24, 2026 astatine 5:50 AM CST 2 min read

Travere Therapeutics Inc. (NASDAQ:TVTX) is 1 of the best stocks for beginners with small wealth successful 2026. On February 19, Travere Therapeutics reported net for Q4 and full-year 2025, highlighting important maturation for its flagship medication, Filspari. The institution achieved quarterly nett merchandise income of $126.6 cardinal and a full-year full of $410.5 million, with Filspari unsocial generating $322 cardinal successful 2025, which was a 144% summation year-over-year.

This maturation was supported by expanded doc confidence, favorable reimbursement pathways covering 96% of the diligent population, and updated objective guidelines. The institution is focused connected respective cardinal objective and regulatory milestones, astir notably the imaginable enlargement of Filspari into FSGS (Focal Segmental Glomerulosclerosis). While the FDA shifted the people enactment day for the Filspari SNDA to April 13 this year, absorption expressed assurance that proteinuria remains a valid surrogate endpoint for afloat approval.

Medical treatments, precocious aesculapian equipment, aesculapian devices

Travere Therapeutics Inc. (NASDAQ:TVTX) has besides resumed tract activation for the Phase 3 Harmony survey of Pegtobatinase to present the archetypal disease-modifying therapy for classical homocystinuria. To enactment these upcoming launches and existing demand, the institution has expanded its tract squad to implicit 100 personnel, targeting the precocious prescriber overlap betwixt IgA nephropathy and FSGS.

Travere Therapeutics Inc. (NASDAQ:TVTX) is simply a biopharmaceutical institution that identifies, develops, and delivers therapies to radical surviving with uncommon kidney and metabolic diseases successful the US.

While we admit the imaginable of TVTX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.

Read Entire Article